This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hearing Loss or Cancer
and you are
between 19 and 50
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

A study to determine the safety, tolerability, and pharmacokinetics of SPI-1005 capsules in healthy adults.

Provided treatments

  • Drug: SPI-1005
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01452607. The sponsor of the trial is Sound Pharmaceuticals, Incorporated and it is looking for 32 volunteers for the current phase.
Official trial title:
A Phase 1, Double-blind, Placebo-controled, Randomized Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SPI-1005 (Ebselen)in Healthy Adult Subjects